Pharma News
Investing in Stability: Q&A With James Saperstein, CEO of FourStory Bio Pharma
Saperstein discusses the current conditions that are impacting investors’ view of the life sciences industry.
Source link
#Investing #Stability #QampA #James #Saperstein #CEO #FourStory #Bio #Pharma